Title : Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

Pub. Date : 2010 Apr 13

PMID : 20354524






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A multiplexed RT-PCR assay was used to identify KRAS-controlled apoptosis regulators after exposure to 5-FU or oxaliplatin. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
2 RESULTS: Oncogenic KRAS sensitised colorectal tumour cells to oxaliplatin and 5-FU in a p53-dependent manner and promoted p53 phosphorylation at Ser37 and Ser392, without affecting p53 stabilisation, p21 induction, or cell-cycle arrest. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
3 CONCLUSION: Oncogenic KRAS determines the cellular response to p53 activation by oxaliplatin or 5-FU, by facilitating apoptosis induction through Noxa. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens